Your browser doesn't support javascript.
loading
Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Strich, Jeffrey R; Ricotta, Emily; Warner, Sarah; Lai, Yi Ling; Demirkale, Cumhur Y; Hohmann, Samuel F; Rhee, Chanu; Klompas, Michael; Palmore, Tara; Powers, John H; Dekker, John P; Adjemian, Jennifer; Matsouaka, Roland; Woods, Christopher W; Danner, Robert L; Kadri, Sameer S.
Afiliación
  • Strich JR; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Ricotta E; US Public Health Service Commissioned Corps, Rockville, Maryland, USA.
  • Warner S; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Lai YL; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Demirkale CY; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hohmann SF; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Rhee C; Vizient, Irving, Texas, USA.
  • Klompas M; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Palmore T; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Powers JH; Hospital Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Dekker JP; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, National Cancer Institute Campus at Frederick, Frederick, Maryland, USA.
  • Adjemian J; Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Matsouaka R; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Woods CW; US Public Health Service Commissioned Corps, Rockville, Maryland, USA.
  • Danner RL; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kadri SS; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Clin Infect Dis ; 72(4): 611-621, 2021 02 16.
Article en En | MEDLINE | ID: mdl-32107536
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacoepidemiología / Farmacorresistencia Bacteriana Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacoepidemiología / Farmacorresistencia Bacteriana Múltiple Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos